Compare Stocks → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CATHNASDAQ:CLOUNASDAQ:INDYNASDAQ:PPH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATHGlobal X S&P 500 Catholic Values ETF$61.65+0.8%$62.01$49.45▼$63.77$812.55M1.0131,435 shs23,647 shsCLOUGlobal X Cloud Computing ETF$20.60+1.1%$21.43$16.00▼$23.67$499.55M0.98319,358 shs122,505 shsINDYiShares India 50 ETF$50.59-0.4%$50.37$42.15▼$51.53$870.15M0.782,958 shs40,465 shsPPHVanEck Pharmaceutical ETF$86.80+0.3%$88.69$74.05▼$91.16$498.23M0.72132,669 shs616,575 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATHGlobal X S&P 500 Catholic Values ETF-0.34%+1.06%-3.00%+3.26%+23.17%CLOUGlobal X Cloud Computing ETF-1.07%+0.94%-6.30%-10.07%+23.23%INDYiShares India 50 ETF+0.75%+2.69%+2.26%+3.85%+20.77%PPHVanEck Pharmaceutical ETF+0.17%+1.94%-3.78%+1.92%+10.44%Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/AN/AN/ACLOUGlobal X Cloud Computing ETFN/AN/AN/AN/AN/AN/AN/AN/AINDYiShares India 50 ETFN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATHGlobal X S&P 500 Catholic Values ETF0.00N/A$67.759.90% UpsideCLOUGlobal X Cloud Computing ETF0.00N/A$24.6219.51% UpsideINDYiShares India 50 ETF0.00N/AN/AN/APPHVanEck Pharmaceutical ETF0.00N/A$95.469.98% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/ACLOUGlobal X Cloud Computing ETFN/AN/AN/AN/AN/AN/AINDYiShares India 50 ETFN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATHGlobal X S&P 500 Catholic Values ETFN/AN/A25.18∞N/AN/AN/AN/AN/ACLOUGlobal X Cloud Computing ETFN/AN/A46.67∞N/AN/AN/AN/AN/AINDYiShares India 50 ETFN/AN/A24.73∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A20.57∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATHGlobal X S&P 500 Catholic Values ETF$0.671.09%N/AN/AN/ACLOUGlobal X Cloud Computing ETF$0.462.23%N/AN/AN/AINDYiShares India 50 ETF$0.190.38%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.561.80%N/AN/AN/ALatest CLOU, CATH, PPH, and INDY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024PPHVanEck Pharmaceutical ETF$0.53284/1/20244/2/20244/5/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/ACLOUGlobal X Cloud Computing ETFN/AINDYiShares India 50 ETFN/APPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/ACLOUGlobal X Cloud Computing ETFN/AINDYiShares India 50 ETFN/APPHVanEck Pharmaceutical ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCATHGlobal X S&P 500 Catholic Values ETF147,00013.18 millionN/AOptionableCLOUGlobal X Cloud Computing ETF147,00024.25 millionN/AOptionableINDYiShares India 50 ETF147,00017.20 millionN/AOptionablePPHVanEck Pharmaceutical ETF147,0005.74 millionN/AOptionableCLOU, CATH, PPH, and INDY HeadlinesSourceHeadlinePPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returnsseekingalpha.com - April 23 at 7:30 AMCanada’s updated guidance on ESG-related investment fund disclosuretheglobeandmail.com - April 18 at 10:38 AMJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focuszacks.com - April 17 at 11:00 AMVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 3 at 8:35 AMVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 1 at 2:26 PMShould You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com - March 8 at 7:21 AMThe Top 3 ETFs to Buy in March 2024investorplace.com - March 7 at 1:43 PM11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yieldsmarkets.businessinsider.com - February 28 at 3:40 PMNavigate to Success With These 4 Pharma Stocks to Buystocknews.com - February 28 at 1:01 PMThe 3 Hottest Healthcare ETFs to Buy in 2024investorplace.com - February 26 at 2:12 PMPPH VanEck Pharmaceutical ETFseekingalpha.com - February 21 at 8:39 PMHealthcare dealmakers see increased M&A, valuations in 2024: KPMGmsn.com - February 20 at 7:16 AMPharma ETF (PPH) Hit a 52-Week Highzacks.com - February 19 at 9:50 AMBig Pharma earnings season in spotlight amid positive sentimentmsn.com - January 28 at 1:06 PM5 ETF Zones Scaling New Highs at the Start of 2024finance.yahoo.com - January 8 at 1:13 PMPfizer in 2024: What to expect?msn.com - December 29 at 1:39 PMGilead in 2024: What to expect?msn.com - December 28 at 1:41 PMETFs to buy and sell as the GLP-1 craze boomscnbc.com - December 6 at 9:53 AM10 Best Performing Healthcare ETFs in 2023uk.finance.yahoo.com - November 14 at 4:43 PMPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your Portfoliomsn.com - November 6 at 1:27 PMPPH ETF Stock Price Historyinvesting.com - November 1 at 5:10 PMPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfoliomsn.com - October 29 at 7:35 AM3 Resilient Pharma Stocks to Buy This Weekstocknews.com - October 26 at 9:05 PMOzempic craze drives big flows into pharmaceutical, Danish fundsmsn.com - October 25 at 12:42 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s Portfolio3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackStock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSNOW CEO Buys $5 Million of Stock. What's He See That We Don't?April 3, 2024 6:15 AMView SNOW CEO Buys $5 Million of Stock. What's He See That We Don't?Extreme Networks Snags an Upgrade on Inventory NormalizationApril 23, 2024 9:02 AMView Extreme Networks Snags an Upgrade on Inventory NormalizationAll Headlines Company DescriptionsGlobal X S&P 500 Catholic Values ETFNASDAQ:CATHThe Global X S&P 500 Catholic Values ETF (CATH) is an exchange-traded fund that is based on the S&P 500 Catholic Values index. The fund tracks an index of US large-cap stocks selected from the S&P 500. The cap-weighted index omits companies from certain industries at odds with Catholic values. CATH was launched on Apr 18, 2016 and is managed by Global X.Global X Cloud Computing ETFNASDAQ:CLOUThe Global X Cloud Computing ETF (CLOU) is an exchange-traded fund that is based on the Indxx Global Cloud Computing index. The fund provides exposure to a market-cap weighted global equity index of companies involved in the cloud computing industry. CLOU was launched on Apr 12, 2019 and is managed by Global X.iShares India 50 ETFNASDAQ:INDYiShares India 50 ETF, formerly iShares S&P India Nifty 50 Index Fund, seeks investment results that correspond generally to the price and yield performance of the S&P CNX Nifty Index (the Index). The Index measures the equity performance of the top 50 companies by market capitalization that trade in the Indian market. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.VanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.